Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $48,622 | 1,631 | 24.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $46,781 | 41 | 23.6% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $38,675 | 15 | 19.5% |
| Unspecified | $21,487 | 4 | 10.8% |
| Consulting Fee | $20,126 | 15 | 10.2% |
| Travel and Lodging | $18,522 | 57 | 9.3% |
| Compensation for serving as faculty or as a speaker for a medical education program | $2,000 | 2 | 1.0% |
| Entertainment | $1,366 | 4 | 0.7% |
| Education | $297.39 | 9 | 0.2% |
| Gift | $239.32 | 4 | 0.1% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Nevro Corp. | $104,202 | 639 | $0 (2024) |
| Depomed, Inc. | $34,509 | 111 | $0 (2017) |
| Stimwave Technologies Incorporated | $15,340 | 58 | $0 (2022) |
| Assertio Therapeutics, Inc. | $8,326 | 43 | $0 (2020) |
| Boston Scientific Corporation | $6,228 | 54 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $5,514 | 18 | $0 (2021) |
| Teva Pharmaceuticals USA, Inc. | $3,829 | 195 | $0 (2024) |
| Curonix LLC | $3,470 | 14 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $2,407 | 4 | $0 (2022) |
| Allergan, Inc. | $1,642 | 27 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $8,690 | 133 | Nevro Corp. ($3,370) |
| 2023 | $4,269 | 127 | Nevro Corp. ($2,264) |
| 2022 | $31,042 | 154 | Nevro Corp. ($26,744) |
| 2021 | $15,201 | 214 | Biohaven Pharmaceuticals, Inc. ($5,372) |
| 2020 | $19,961 | 261 | Nevro Corp. ($14,749) |
| 2019 | $52,743 | 423 | Nevro Corp. ($41,814) |
| 2018 | $27,391 | 240 | Nevro Corp. ($9,729) |
| 2017 | $38,820 | 230 | Depomed, Inc. ($34,509) |
All Payment Transactions
1,782 individual payment records from CMS Open Payments — Page 1 of 72
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: PAIN MANAGEMENT | ||||||
| 12/18/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $4.74 | General |
| Category: PAIN | ||||||
| 12/17/2024 | PFIZER INC. | ZAVZPRET (Drug) | Food and Beverage | In-kind items and services | $6.00 | General |
| Category: PAIN | ||||||
| 12/13/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $7.55 | General |
| Category: PAIN | ||||||
| 12/12/2024 | Curonix LLC | PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) | Food and Beverage | In-kind items and services | $10.27 | General |
| Category: PAIN MANAGEMENT | ||||||
| 12/11/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Central Nervous System | ||||||
| 12/10/2024 | Collegium Pharmaceutical, Inc. | Nucynta (Drug) | Food and Beverage | Cash or cash equivalent | $11.56 | General |
| Category: Opioid Analgesic | ||||||
| 12/09/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $30.18 | General |
| Category: NEUROLOGY | ||||||
| 12/02/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $32.50 | General |
| 11/20/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: PAIN | ||||||
| 11/13/2024 | PFIZER INC. | ZAVZPRET (Drug) | Food and Beverage | In-kind items and services | $2.75 | General |
| Category: PAIN | ||||||
| 11/12/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $12.34 | General |
| Category: Opioid Analgesic | ||||||
| 11/08/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: PAIN | ||||||
| 11/07/2024 | Nevro Corp. | Vyrsa V1 (Device) | Consulting Fee | Cash or cash equivalent | $1,470.00 | General |
| Category: SI Joint Fixation | ||||||
| 11/06/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 11/05/2024 | Curonix LLC | PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) | Food and Beverage | In-kind items and services | $10.07 | General |
| Category: PAIN MANAGEMENT | ||||||
| 11/04/2024 | PFIZER INC. | ZAVZPRET (Drug) | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: PAIN | ||||||
| 11/02/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $40.21 | General |
| Category: General - Pain Management_NMD | ||||||
| 11/01/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $25.97 | General |
| Category: Spinal Cord Stimulator | ||||||
| 10/30/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $148.60 | General |
| Category: Spinal Cord Stimulator | ||||||
| 10/30/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $46.01 | General |
| Category: Spinal Cord Stimulator | ||||||
| 10/28/2024 | Collegium Pharmaceutical, Inc. | Nucynta (Drug) | Food and Beverage | Cash or cash equivalent | $13.14 | General |
| Category: Opioid Analgesic | ||||||
| 10/27/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $123.31 | General |
| Category: Spinal Cord Stimulator | ||||||
| 10/26/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $44.50 | General |
| Category: Spinal Cord Stimulator | ||||||
| 10/25/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | Cash or cash equivalent | $130.20 | General |
| Category: Spinal Cord Stimulator | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| CA2018-1 US RECHARGE | Nevro Corp. | $21,441 | 3 |
| Evoke Study | Saluda Medical Americas, Inc. | $45.40 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 40 | 4,968 | 8,660 | $3.3M | $943,759 |
| 2022 | 36 | 5,226 | 9,293 | $2.6M | $765,739 |
| 2021 | 41 | 4,492 | 8,658 | $2.1M | $639,760 |
| 2020 | 42 | 4,203 | 8,057 | $2.1M | $599,126 |
All Medicare Procedures & Services
171 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 250 | 294 | $379,260 | $143,086 | 37.7% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 247 | 476 | $342,720 | $130,325 | 38.0% |
| 63650 | Insertion of spinal neurostimulator electrode array through skin | Office | 2023 | 48 | 96 | $656,640 | $125,697 | 19.1% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 209 | 348 | $177,480 | $66,924 | 37.7% |
| 64634 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 86 | 177 | $132,750 | $48,140 | 36.3% |
| 64633 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 87 | 101 | $130,290 | $45,338 | 34.8% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 169 | 205 | $147,600 | $43,646 | 29.6% |
| 64555 | Insertion of peripheral nerve neurostimulator electrode through skin | Office | 2023 | 18 | 27 | $178,200 | $37,672 | 21.1% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 208 | 344 | $89,440 | $35,351 | 39.5% |
| 0275T | Removal of bone from lower spine for decompression of nerve tissue using imaging guidance, accessed through the skin | Facility | 2023 | 46 | 49 | $136,710 | $34,583 | 25.3% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Office | 2023 | 92 | 152 | $82,080 | $30,434 | 37.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 254 | 311 | $111,960 | $26,410 | 23.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 256 | 256 | $76,800 | $20,983 | 27.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 263 | 319 | $81,345 | $19,955 | 24.5% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Office | 2023 | 359 | 462 | $69,300 | $17,733 | 25.6% |
| 64491 | Injection of upper or middle spine facet joint using imaging guidance, second level | Office | 2023 | 92 | 152 | $41,040 | $15,854 | 38.6% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Office | 2023 | 70 | 79 | $59,250 | $15,176 | 25.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 112 | 112 | $53,760 | $14,013 | 26.1% |
| 27307 | Incision of multiple tendons of thigh or hamstring muscle | Facility | 2023 | 28 | 29 | $34,800 | $9,726 | 27.9% |
| 63650 | Insertion of spinal neurostimulator electrode array through skin | Facility | 2023 | 18 | 36 | $46,512 | $8,464 | 18.2% |
| 64454 | Injection of anesthetic agent and/or steroid into knee nerve branch using imaging guidance | Office | 2023 | 34 | 43 | $28,380 | $7,859 | 27.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 143 | 160 | $24,000 | $6,169 | 25.7% |
| 64624 | Destruction of nerve branches of knee using imaging guidance | Office | 2023 | 13 | 14 | $15,960 | $4,681 | 29.3% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2023 | 26 | 32 | $15,360 | $4,410 | 28.7% |
| 77002 | Fluoroscopic guidance for needle placement | Office | 2023 | 47 | 52 | $17,160 | $4,271 | 24.9% |
About Dr. Ellen Lin, MD
Dr. Ellen Lin, MD is a Pain Medicine healthcare provider based in San Antonio, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1548273501.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ellen Lin, MD has received a total of $198,116 in payments from pharmaceutical and medical device companies, with $8,690 received in 2024. These payments were reported across 1,782 transactions from 70 companies. The most common payment nature is "Food and Beverage" ($48,622).
As a Medicare-enrolled provider, Lin has provided services to 18,889 Medicare beneficiaries, totaling 34,668 services with total Medicare billing of $2.9M. Data is available for 4 years (2020–2023), covering 171 distinct procedure/service records.
Practice Information
- Specialty Pain Medicine
- Location San Antonio, TX
- Active Since 08/14/2006
- Last Updated 05/11/2015
- Taxonomy Code 2081P2900X
- Entity Type Individual
- NPI Number 1548273501
Products in Payments
- Senza Spinal Cord Stimulation System (Device) $66,875
- Nucynta (Drug) $28,753
- Nevro (Device) $21,441
- Gralise (Drug) $14,181
- Omnia (Device) $10,252
- NURTEC ODT (Drug) $8,238
- Senza (Device) $4,025
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) $3,470
- SPECTRA WAVEWRITER (Device) $3,387
- AJOVY (Biological) $2,749
- StimQ Receiver Stimulator Kit Channel A US w/Receiver (Device) $2,290
- UBRELVY (Drug) $1,755
- Vyrsa V1 (Device) $1,609
- CFNS StimQ Peripheral Nerve StimulatorSystem (Device) $1,451
- mild Device Kit (Device) $1,177
- PRECISION (Device) $1,147
- AJOVY (Drug) $960.24
- InSpan (Device) $703.20
- SPRIX (Drug) $586.16
- Superion ISS (Device) $548.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pain Medicine Doctors in San Antonio
Dr. Maxim Eckmann, Md, MD
Pain Medicine — Payments: $299,172
Maged Mina, Md, MD
Pain Medicine — Payments: $218,491
Dr. Prabhdeep Grewal, Md, MD
Pain Medicine — Payments: $51,411
William Tisdall, M.d, M.D
Pain Medicine — Payments: $49,129
Bryan Lai
Pain Medicine — Payments: $34,641
Dr. Ricardo Alvarado, Md, MD
Pain Medicine — Payments: $26,972